GT201500038A - Composicion de difenidol de liberacion prolongada. - Google Patents

Composicion de difenidol de liberacion prolongada.

Info

Publication number
GT201500038A
GT201500038A GT201500038A GT201500038A GT201500038A GT 201500038 A GT201500038 A GT 201500038A GT 201500038 A GT201500038 A GT 201500038A GT 201500038 A GT201500038 A GT 201500038A GT 201500038 A GT201500038 A GT 201500038A
Authority
GT
Guatemala
Prior art keywords
agents
prolonged release
diffenidol
composition
pharmaceutical composition
Prior art date
Application number
GT201500038A
Other languages
English (en)
Inventor
Resendiz-Hernandez Guadalupe
Original Assignee
Invekra S A P I De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invekra S A P I De C V filed Critical Invekra S A P I De C V
Publication of GT201500038A publication Critical patent/GT201500038A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN DESCRIBE UNA COMPOSICIÓN FARMACÉUTICA DE DIFENIDOL DE LIBERACIÓN PROLONGADA QUE COMPRENDE: A) DE 15 A 50% DE CLORHIDRATO DE DIFENIDOL; B) DE 0.1 A 20% DE UNO O MÁS AGENTES AGLUTINANTES; C) DE 5 A 90% DE UNO O MÁS AGENTES DILUENTES; D) DE 5 A 50% DE UNO O MÁS AGENTES MODIFICADORES DE LA LIBERACIÓN; E) DE 0.25 A 10% DE UNO O MÁS AGENTES LUBRICANTES; Y F) 0.1 A 10% DE AGENTES DESLIZANTES. DE MANERA PREFERIDA, ESTA COMPOSICIÓN FARMACÉUTICA SE ADMINISTRA POR VÍA ORAL Y SE ENCUENTRA EN FORMA DE TABLETA.
GT201500038A 2013-01-16 2015-02-19 Composicion de difenidol de liberacion prolongada. GT201500038A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013000662A MX356789B (es) 2013-01-16 2013-01-16 Composición de difenidol de liberación prolongada.

Publications (1)

Publication Number Publication Date
GT201500038A true GT201500038A (es) 2019-08-02

Family

ID=51209070

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201500038A GT201500038A (es) 2013-01-16 2015-02-19 Composicion de difenidol de liberacion prolongada.

Country Status (11)

Country Link
US (1) US10188610B2 (es)
BR (1) BR112015011351B1 (es)
CA (1) CA2889283C (es)
CL (1) CL2015001128A1 (es)
CR (1) CR20150275A (es)
DO (1) DOP2015000089A (es)
EC (1) ECSP15030460A (es)
GT (1) GT201500038A (es)
MX (1) MX356789B (es)
PE (1) PE20150888A1 (es)
WO (1) WO2014111799A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108283625A (zh) * 2018-04-26 2018-07-17 江苏四环生物制药有限公司 一种盐酸地芬尼多片的制备方法
CN110638775A (zh) * 2019-10-25 2020-01-03 仁和堂药业有限公司 一种盐酸地芬尼多片剂及其应用
CN110638776A (zh) * 2019-10-25 2020-01-03 仁和堂药业有限公司 盐酸地芬尼多片的制备工艺
CN110934842A (zh) * 2019-11-26 2020-03-31 卓和药业集团有限公司 盐酸地芬尼多片的制备方法
CN112315925A (zh) * 2020-11-16 2021-02-05 仁和堂药业有限公司 盐酸米安色林片及其制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
WO1991006281A1 (en) * 1989-10-26 1991-05-16 Nippon Shinyaku Co., Ltd. Gastric preparation
CN1935140A (zh) 2005-09-19 2007-03-28 长沙佰川医药科技开发有限责任公司 复方盐酸地芬尼多分散片剂及其制备方法
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
US8574625B2 (en) * 2007-05-30 2013-11-05 Wockhardt Ltd. Tablet dosage form
KR101051630B1 (ko) * 2008-10-02 2011-07-26 한국유나이티드제약 주식회사 용출률과 복용편의성이 향상된 트리메부틴 서방정
EP2403486A1 (en) * 2009-03-03 2012-01-11 XenoPort, Inc. Sustained release oral dosage forms of an r-baclofen prodrug

Also Published As

Publication number Publication date
DOP2015000089A (es) 2015-05-15
ECSP15030460A (es) 2017-08-31
US20150352051A1 (en) 2015-12-10
CA2889283C (en) 2020-12-29
WO2014111799A1 (es) 2014-07-24
PE20150888A1 (es) 2015-06-08
US10188610B2 (en) 2019-01-29
MX2013000662A (es) 2014-07-16
BR112015011351B1 (pt) 2021-11-23
CA2889283A1 (en) 2014-07-24
CR20150275A (es) 2015-07-08
CL2015001128A1 (es) 2015-10-09
BR112015011351A2 (pt) 2017-07-11
MX356789B (es) 2018-06-12

Similar Documents

Publication Publication Date Title
CY1120529T1 (el) Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων
CY1119361T1 (el) 3,4-διυδροισοκινολιν-2(1h)-υλικες ενωσεις
BR112015016930A2 (pt) formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina
GT201500038A (es) Composicion de difenidol de liberacion prolongada.
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
FR3022462B1 (fr) Composition orale d'anticorps anti-tnfalpha
BR112016024235A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
CO7131387A2 (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
BR112015016033A2 (pt) composições e métodos para tratamento de infecções por bactérias
BR112015016995B8 (pt) Uso de agonistas do receptor alfa 7 nicotínico de acetilcolina
AR098614A1 (es) Compuesto para el tratamiento de hipoglicemia severa
UY35004A (es) Forma amorfa estabilizada de la agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que la contienen
TH173412A (th) องค์ประกอบดูแลช่องปาก
CN302331603S (zh) 滑轨组件
CN302513130S (zh) 音乐牙刷(sg-950)
CN302034439S (zh) 拨圈式密码锁
CN302291874S (zh) 自动门
AR092570A1 (es) Composicion oral que contiene dapoxetina como base libre
TH1501001478A (th) องค์ประกอบทางเภสัชกรรมสำหรับการให้ทางปากซึ่งมีการละลาย และ/หรือ การดูดซึมดีขึ้น
CN302103642S (zh) 柜子
CU20140133A7 (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
CN302390890S (zh) 瓶子
CN302178353S (zh) 家用牙齿美白仪(ea-003)
CN302498366S (zh) 血球仪(d6580)
TH153195A (th) ตัวยับยั้งนีพริไลซิน